The Society for Immunotherapy of Cancer''s handbook,SITC’s Guide to Managing Immunotherapy Toxicity, is a practical reference to managing side effects associated with FDA-approved cancer immunotherapy drugs. Separated into two parts, Part I contains chapter-based overviews of immune checkpoint inhibitors in the clinic, starting with anti-CTLA4 agents, anti-PD1/PD-L1 agents, and approved immunotherapeutic combinations. These chapters cover relevant mechanisms of action, indications, and toxicities seen while combating early, advanced, and metastatic stages in cancer patients. Part II is structured by common and uncommon toxicities that affect major organ sites throughout the body. It begins with a general summary of principles and management options followed by chapters focusing on specific toxicities such as rash and mucosal irritation, muscle and joint toxicity, diarrhea and colitis, pneumonitis, endocrine toxicities, neurological toxicities, cardiac toxicity, renal toxicity, hematologic toxicity, and ocular toxicities. Each chapter provides guidance on how to assess and treat the toxicity and how to support the patient through acute and chronic effects with detailed summary tables for quick reference. Part II concludes with chapters covering management of special patient populations, including patients with autoimmune disease and geriatric patients, treatment and management of fatigue, and a final chapter dedicated to cost effectiveness and the toll of financial toxicity on patients and caregivers.
With chapters written by world-recognized leaders in the immuno-oncology field, this text provides thorough coverage of the toxicity and management of adverse effects for immune checkpoint inhibitors. It is an indispensable resource for clinical oncologists, emergency physicians, hospitalists and other medical practitioners in both the hospital and community clinic settings, especially as the use of immune checkpoint inhibitors becomes a fixture in oncology care.
Key Features:
The Society for Immunotherapy of Cancer''s handbook,SITC’s Guide to Managing Immunotherapy Toxicity, is a practical reference to managing side effects associated with FDA-approved cancer immunotherapy drugs. Separated into two parts, Part I contains chapter-based overviews of immune checkpoint inhibitors in the clinic, starting with anti-CTLA4 agents, anti-PD1/PD-L1 agents, and approved immunotherapeutic combinations. These chapters cover relevant mechanisms of action, indications, and toxicities seen while combating early, advanced, and metastatic stages in cancer patients. Part II is structured by common and uncommon toxicities that affect major organ sites throughout the body. It begins with a general summary of principles and management options followed by chapters focusing on specific toxicities such as rash and mucosal irritation, muscle and joint toxicity, diarrhea and colitis, pneumonitis, endocrine toxicities, neurological toxicities, cardiac toxicity, renal toxicity, hematologic toxicity, and ocular toxicities. Each chapter provides guidance on how to assess and treat the toxicity and how to support the patient through acute and chronic effects with detailed summary tables for quick reference. Part II concludes with chapters covering management of special patient populations, including patients with autoimmune disease and geriatric patients, treatment and management of fatigue, and a final chapter dedicated to cost effectiveness and the toll of financial toxicity on patients and caregivers.
With chapters written by world-recognized leaders in the immuno-oncology field, this text provides thorough coverage of the toxicity and management of adverse effects for immune checkpoint inhibitors. It is an indispensable resource for clinical oncologists, emergency physicians, hospitalists and other medical practitioners in both the hospital and community clinic settings, especially as the use of immune checkpoint inhibitors becomes a fixture in oncology care.
Key Features:
Prisen for levering afhænger af typen af dit medlemskab, eller om du ikke har et medlemskab.
Hvis du ikke har et medlemsskab er priserne som følger:
Levering til pakkeshop | 39,95 kr. pr. ordre |
Hjemmelevering | 59,90 kr. pr. ordre |
Med et guldmedlemsskab er leveringspriserne:
Levering til pakkeshop. Ordrer under 250 kr. | 34,95 kr. pr. ordre |
Levering til pakkeshop. Ordrer over 250 kr. | 24,95 kr. pr. ordre |
Hjemmelevering. Ordrer under 250 kr. | 59,90 kr. pr. ordre |
Hjemmelevering. Ordrer over 250 kr. | 49,90 kr. pr. ordre |
Med et plating- eller streaming medlemsskab er leveringspriserne:
Levering til pakkeshop. Ordrer under 250 kr. | 24,95 kr. pr. ordre |
Levering til pakkeshop. Ordrer over 250 kr. | 0 kr. pr. ordre |
Hjemmelevering. Ordrer under 250 kr. | 44,90 kr. pr. ordre |
Hjemmelevering. Ordrer over 250 kr. | 19,95 kr. pr. ordre |
Bemærk venligst, at vi forbeholder os retten til at ændre i et fragtbeløb efter ordreafgivelse, hvis man som kunde har opnået en særlig fragtpris pga. køb for over 250 kr. og efterfølgende retter i sin ordre, så ordrebeløbet kommer under 250 kr. Ovenstående fragtpriser for ordrer under 250 kr. vil i så fald være gældende.
Levering
Varerne sendes indenfor 1-6 hverdage. Den konkrete leveringstid står oplyst ved hver enkelt vare. Levering sker med PostNord eller DAO distribution. Vi leverer kun i Danmark og ikke til Grønland og Færøerne.
Vær opmærksom på, at DAO ofte leverer om natten, og at der ikke skal kvitteres for modtagelse af pakken fra DAO. Hvis ikke DAO kan levere pakken forsvarligt ved dør eller i postkasse,
vil pakken i stedet blive leveret til nærmeste pakkeshop, også selvom du har betalt for hjemmelevering.